Sex Reassignment Surgery Market - Top Companies and Manufacturers

Companies Dominating the Sex Reassignment Surgery Landscape

The industry's leading service providers are always updating their technologies to maintain an edge over rivals and to guarantee dependability, effectiveness, and security. In order to obtain a competitive edge over their rivals and seize a substantial portion of the market, these firms concentrate on collaboration, product improvements, and partnerships.

Bupa Group
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Mayo Clinic
Amish Hospital
Boston Medical Center
Cleveland Clinic
Transgender Surgery Institute
Plastic Surgery Group of Rochester
The Johns Hopkins University
IM Gender Clinic
GRS Montreal Clinic

Browse Key Market Insights with Data Illustration:

Sex Reassignment Surgery Market Size | Growth Trends 2036

In the News

Bupa UK Insurance has announced a suite of new offerings for its UK business customers under the brand name Inclusive Health. The new offerings supplement Bupa's already comprehensive portfolio of inclusive health benefits. Bupa presently provides a best-in-class gender dysphoria proposition that includes comprehensive assistance for employees during their transition, including gender reaffirmation surgery.
Mayo Clinic Urogynecology and Radiology anatomic modeling, in collaboration with colleagues from three other institutions, developed a 3D-printed, anatomically customizable vaginal mold for use postoperatively after vaginoplasty. These findings were published in the journal Obstetrics & Gynecology in August 2022. Given the favorable outcome of the case presented in this journal, as well as the increasing availability of 3D printing, the study authors believe customized, 3D-printed vaginal molds hold potential for tailored vaginal agenesis treatment.

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of sex reassignment surgery was over USD 670.2 million.

The market size for sex reassignment surgery is projected to cross USD 3.1 billion by the end of 2036 expanding at a CAGR of 1 1.7% during the forecast period i.e., between 2024-2036.

The major players in the market are Bupa Group, Mayo Clinic, Amish Hospital, Boston Medical Center, Cleveland Clinic, Transgender Surgery Institute, Plastic Surgery Group of Rochester, The Johns Hopkins University, IM Gender Clinic, GRS Montreal Clinic, and others.

The female to male segment is anticipated to garner a CAGR of 12% during 2024-2036.

The Europe sex reassignment surgery sector is poised to garner a revenue of 500 million by the end of 2036.

Sex Reassignment Surgery Market - Top Companies and Manufacturers

Companies Dominating the Sex Reassignment Surgery Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the sex reassignment surgery industry?

What is the outlook for the sex reassignment surgery market?

Who are the major players dominating the sex reassignment surgery landscape?

Which segment will capture the significant market share for sex reassignment surgery by 2036?

Which region will provide more opportunities for the sex reassignment surgery business in the near future?